Two prescription omega-3s are commonly confused. Lovaza (EPA+DHA) treats severe hypertriglyceridemia; Vascepa (pure EPA) is the only one with cardiovascular outcomes evidence. Plus: where OTC fish oil and krill oil fit, and the dose-dependent atrial fibrillation signal.